A detailed history of Quest Partners LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 2,013 shares of MRNA stock, worth $65,623. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,013
Previous 4,567 55.92%
Holding current value
$65,623
Previous $305 Million 72.58%
% of portfolio
0.01%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

SELL
$36.85 - $63.93 $94,114 - $163,277
-2,554 Reduced 55.92%
2,013 $83.7 Million
Q3 2024

Nov 07, 2024

BUY
$63.64 - $125.14 $205,111 - $403,326
3,223 Added 239.81%
4,567 $305 Million
Q2 2024

Aug 06, 2024

BUY
$101.21 - $166.61 $134,912 - $222,091
1,333 Added 12118.18%
1,344 $160 Million
Q1 2024

May 09, 2024

BUY
$85.37 - $115.44 $939 - $1,269
11 New
11 $1.17 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $12.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.